<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="kleefstra" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">kleefstra</book-part-id>
      <title-group>
        <title>Kleefstra Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonyms: 9q Subtelomeric Deletion Syndrome, 9q34.3 Microdeletion Syndrome, 9qSTDS</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kleefstra</surname>
            <given-names>Tjitske</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Human Genetics<break/>Radboud University Medical Center<break/>Nijmegen, The Netherlands</aff>
          <email>tjitske.kleefstra@radboudumc.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nillesen</surname>
            <given-names>Willy M</given-names>
          </name>
          <degrees>BSc</degrees>
          <aff>Department of Human Genetics<break/>Radboud University Medical Center<break/>Nijmegen, The Netherlands</aff>
          <email>willy.nillesen@radboudumc.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yntema</surname>
            <given-names>Helger G</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Department of Human Genetics<break/>Radboud University Medical Center<break/>Nijmegen, The Netherlands</aff>
          <email>helger.ijntema@radboudumc.nl</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2010-10-05" date-type="created">
          <day>5</day>
          <month>10</month>
          <year>2010</year>
        </date>
        <date iso-8601-date="2015-05-07" date-type="updated">
          <day>7</day>
          <month>5</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="kindler" document-type="chapter">Kindler Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="krabbe" document-type="chapter">Krabbe Disease</related-object>
      <abstract id="kleefstra.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Kleefstra syndrome is characterized by intellectual disability, childhood hypotonia, and distinctive facial features. The majority of individuals function in the moderate to severe spectrum of intellectual disability although a few individuals have mild delay and total IQ around 70. Although most have severe expressive speech delay with little speech development, general language development is usually at a higher level, making nonverbal communication possible. A complex pattern of other findings can also be observed including heart defects, renal/urologic defects, genital defects in males, severe respiratory infections, epilepsy/febrile seizures, autistic-like features in childhood, and extreme apathy or catatonic-like features after puberty.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>About 75% of Kleefstra syndrome is caused by a heterozygous microdeletion at chromosome 9q34.3 that includes at least part of <italic toggle="yes">EHMT1</italic>, and about 25% by a heterozygous intragenic <italic toggle="yes">EHMT1</italic> pathogenic variant.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Ongoing routine care by a multidisciplinary team specializing in the care of children or adults with intellectual disability. Referral to age-appropriate early-childhood intervention programs, special education programs, or vocational training; speech/language therapy, physical and occupational therapy, and sensory integration therapy; specialized care for those with extreme behavior problems, movement disorders, sleep disorders, and/or epilepsy; standard treatment for cardiac, renal, urologic, hearing loss, and other medical issues.</p>
          <p><italic toggle="yes">Surveillance:</italic> Monitoring as needed of cardiac and renal/urologic abnormalities.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Kleefstra syndrome, caused by a microdeletion at 9q34.3 or pathogenic variants in <italic toggle="yes">EHMT1,</italic> is inherited in an autosomal dominant manner. Almost all cases reported to date have been <italic toggle="yes">de novo</italic>; rarely, recurrence in a family has been reported when a parent has a balanced translocation involving the 9q34.3 region or somatic mosaicism for an interstitial 9q34.3 microdeletion. Except for individuals with somatic mosaicism for a 9q34.3 microdeletion, no individuals with Kleefstra syndrome have been known to reproduce. Prenatal testing may be offered to unaffected parents of a child with a 9q34.3 microdeletion or an <italic toggle="yes">EHMT1</italic> pathogenic variant because of the increased risk of recurrence associated with the possibility of germline mosaicism, somatic mosaicism including the germline, or a balanced chromosome translocation.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="kleefstra.Diagnosis">
        <title>Diagnosis</title>
        <p>Kleefstra syndrome is characterized by intellectual disability, childhood hypotonia, and distinctive facial features. A complex pattern of other findings can also be observed [<xref ref-type="bibr" rid="kleefstra.REF.dawson.2002.488">Dawson et al 2002</xref>, <xref ref-type="bibr" rid="kleefstra.REF.cormierdaire.2003.300">Cormier-Daire et al 2003</xref>, <xref ref-type="bibr" rid="kleefstra.REF.stewart.2004.340">Stewart et al 2004</xref>, <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2005.299">Kleefstra et al 2005</xref>, <xref ref-type="bibr" rid="kleefstra.REF.yatsenko.2005.328">Yatsenko et al 2005</xref>, <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2006a.370">Kleefstra et al 2006a</xref>, <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2006b.618">Kleefstra et al 2006b</xref>, <xref ref-type="bibr" rid="kleefstra.REF.stewart.2007.383">Stewart &#x00026; Kleefstra 2007</xref>, <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</xref>, <xref ref-type="bibr" rid="kleefstra.REF.yatsenko.2009.1924">Yatsenko et al 2009</xref>].</p>
        <sec id="kleefstra.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Features that should prompt consideration of Kleefstra syndrome include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Intellectual disability, usually moderate to severe and associated with severe speech delay</p>
            </list-item>
            <list-item>
              <p>Distinctive facial features</p>
            </list-item>
            <list-item>
              <p>Childhood hypotonia</p>
            </list-item>
            <list-item>
              <p>Motor delay</p>
            </list-item>
            <list-item>
              <p>Heart defects</p>
            </list-item>
            <list-item>
              <p>Renal/urologic defects</p>
            </list-item>
            <list-item>
              <p>Genital defects (males)</p>
            </list-item>
            <list-item>
              <p>Severe infections (respiratory)</p>
            </list-item>
            <list-item>
              <p>Epilepsy/febrile seizures</p>
            </list-item>
            <list-item>
              <p>Autistic-like features in childhood</p>
            </list-item>
            <list-item>
              <p>Extreme apathy or catatonic(-like) features postpubertally</p>
            </list-item>
            <list-item>
              <p>Structural brain abnormalities</p>
            </list-item>
            <list-item>
              <p>White matter abnormalities</p>
            </list-item>
          </list>
        </sec>
        <sec id="kleefstra.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>Establishing the diagnosis of Kleefstra syndrome in a proband requires detection of a 9q34.3 microdeletion with involvement of at least part of <italic toggle="yes">EHMT1</italic> or detection of an <italic toggle="yes">EHMT1</italic> pathogenic variant (<xref ref-type="table" rid="kleefstra.T.summary_of_molecular_genetic">Table 1</xref>) [<xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2006a.370">Kleefstra et al 2006a</xref>, <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</xref>]. <italic toggle="yes">EHMT1</italic> inactivation accounts for the majority of features in Kleefstra syndrome.</p>
          <p>Kleefstra syndrome is caused by one of two mechanisms:</p>
          <list list-type="bullet">
            <list-item>
              <p>Microdeletion of 9q34.3, accounting for about 75% of Kleefstra syndrome. In 28 unrelated individuals with a 9q34.3 microdeletion, three distinct categories were identified [<xref ref-type="bibr" rid="kleefstra.REF.yatsenko.2009.1924">Yatsenko et al 2009</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>50% bona fide <italic toggle="yes">de novo</italic> terminal deletions</p>
                </list-item>
                <list-item>
                  <p>25% interstitial deletions</p>
                </list-item>
                <list-item>
                  <p>25% complex rearrangements or derivative chromosomes</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>An <italic toggle="yes">EHMT1</italic> pathogenic variant, accounting for about 25% of Kleefstra syndrome.</p>
            </list-item>
          </list>
          <p>Molecular testing approaches can include <bold>a genomic approach, <italic toggle="yes">EHMT1</italic> gene<italic toggle="yes">-</italic>targeted deletion/duplication analysis</bold> and <bold><italic toggle="yes">EHMT1</italic> sequence analysis.</bold></p>
          <p><bold>Genomic approach.</bold> Because of the complex clinical presentation of Kleefstra syndrome, the majority (~70%) of affected individuals are identified by a genome-wide screen for deletions/duplications. Chromosome microarray analysis (CMA) can detect the deletion in a proband. The ability to size the deletion depends on the type of microarray used and the density of probes in the 9q34.3 region.</p>
          <p><bold><italic toggle="yes">EHMT1</italic> gene<italic toggle="yes">-</italic>targeted deletion/duplication analysis.</bold> Approximately 5% of individuals with Kleefstra syndrome have an intragenic deletion detectable by an assay designed to detect single-exon deletions or duplications (e.g., multiplex ligation-dependent probe amplification [MLPA], qPCR, and gene-targeted CMA). Deletions that are not intragenic but too small to be detected by CMA (e.g., containing the last part of <italic toggle="yes">C90RF37</italic> and the first exon of <italic toggle="yes">EHMT1</italic>) require such gene-targeted methods designed for this region for detection.</p>
          <p>Note: (1) FISH cannot size the deletion routinely. (2) The 9q34.3 microdeletion cannot be identified by routine chromosome analysis.</p>
          <p><bold><italic toggle="yes">EHMT1</italic> sequence analysis.</bold> Sequence analysis of the <italic toggle="yes">EHMT1</italic> coding region detects a pathogenic variant in approximately 25% of probands.</p>
          <table-wrap id="kleefstra.T.summary_of_molecular_genetic" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Kleefstra Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_kleefstra.T.summary_of_molecular_genetic_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_kleefstra.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_kleefstra.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_kleefstra.T.summary_of_molecular_genetic_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">EHMT1</italic>
                  </td>
                  <td headers="hd_h_kleefstra.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>3</sup> (genomic approach)</td>
                  <td headers="hd_h_kleefstra.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~70%</td>
                </tr>
                <tr>
                  <td headers="hd_h_kleefstra.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_kleefstra.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~5%</td>
                </tr>
                <tr>
                  <td headers="hd_h_kleefstra.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_kleefstra.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~25%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="kleefstra.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="kleefstra" object-id="kleefstra.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="kleefstra.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="kleefstra.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="kleefstra.TF.1.3">
                <label>3. </label>
                <p>Deletion/duplication analysis (genomic approach) detects deletion of 9q34.3 (<italic toggle="yes">de novo</italic> terminal deletions, complex rearrangements or derivative chromosomes, interstitial deletion) using a chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="kleefstra.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic <italic toggle="yes">EHMT1</italic> deletions or duplications. Examples of methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and gene-targeted microarray designed to detect single exon deletions or duplications.</p>
              </fn>
              <fn id="kleefstra.TF.1.5">
                <label>5. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="kleefstra.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="kleefstra.Clinical_Description">
          <title>Clinical Description</title>
          <p>Kleefstra syndrome has a clinically recognizable phenotype that includes physical, developmental, and behavioral features. Males and females are affected equally [<xref ref-type="bibr" rid="kleefstra.REF.stewart.2004.340">Stewart et al 2004</xref>, <xref ref-type="bibr" rid="kleefstra.REF.yatsenko.2005.328">Yatsenko et al 2005</xref>, <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2006b.618">Kleefstra et al 2006b</xref>, <xref ref-type="bibr" rid="kleefstra.REF.stewart.2007.383">Stewart &#x00026; Kleefstra 2007</xref>, <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</xref>, <xref ref-type="bibr" rid="kleefstra.REF.willemsen.2012.202">Willemsen et al 2012</xref>].</p>
          <p>Birth weight is usually within the normal or above-normal range; in childhood, weight increases leading to obesity (50%) [<xref ref-type="bibr" rid="kleefstra.REF.cormierdaire.2003.300">Cormier-Daire et al 2003</xref>, <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</xref>, <xref ref-type="bibr" rid="kleefstra.REF.willemsen.2012.202">Willemsen et al 2012</xref>]. The facial appearance is characterized by a brachy(-micro)cephaly, broad forehead, synophrys, unusual shape of eyebrows (arched or straight), mildly upslanted palpebral fissures, midface retrusion, thickened ear helices, short nose with anteverted nares, fleshy everted vermilion of the lower lip and exaggerated cupid&#x02019;s bow or "tented" appearance of the vermilion of the upper lip, and protruding tongue and relative prognathism (<xref ref-type="fig" rid="kleefstra.F1">Figure 1</xref>, <xref ref-type="fig" rid="kleefstra.F2">Figure 2</xref>).</p>
          <p>With age, the facial appearance becomes coarser, with persisting midface retrusion and prognathism. An increased frequency of dental anomalies, specifically neonatal teeth and retention of primary dentition, has been observed.</p>
          <p>Individuals with Kleefstra syndrome exhibit a range of cognitive and adaptive functioning, with the majority of individuals functioning in the moderate to severe spectrum of intellectual disability, although few individuals with only mild delay and total IQ (TIQ) around 70 are known. Most affected individuals have severe expressive speech delay with hardly any speech development, whereas general language development is usually at a higher level; thus, sign language or use of pictograms is of value to many affected individuals.</p>
          <p>Motor development is impaired by childhood hypotonia, but almost all individuals achieve independent walking after age two to three years.</p>
          <p>In a significant number of individuals with Kleefstra syndrome, congenital defects are observed. In 50% of individuals a (conotruncal) heart defect is present. Abnormalities that have been reported are ASD/VSD, tetralogy of Fallot, aortic coarctation, bicuspid aortic valve, and pulmonic stenosis. In a number of individuals atrial flutter has been reported.</p>
          <p>Renal defects, seen in 10%-30% of cases, comprise vesico-ureteral reflux (VUR), hydronephrosis, renal cysts, and chronic renal insufficiency. Genital defects such as hypospadias, cryptorchidism, and small penis are reported in 30% of males</p>
          <p>Several affected individuals have had talipes equinovarus. Other abnormalities that have been observed are epigastric hernia, tracheo-/bronchomalacia with respiratory insufficiency, and gastroesophageal reflux.</p>
          <p>Seizures reported in 30% can include tonic-clonic seizures, absence seizures, and complex partial epilepsy.</p>
          <p>Besides issues with social behavior, the behavioral phenotype includes sleep disturbances, stereotypies, mild self-injurious behaviors, and autism spectrum disorder usually recognized in early childhood. A few reports of adolescents and adults revealed progressive extreme apathy and catatonic(-like) behavior [<xref ref-type="bibr" rid="kleefstra.REF.verhoeven.2010.536">Verhoeven et al 2010</xref>]. Sleep disturbance is characterized by frequent nocturnal and early morning awakenings as well as excessive daytime wakefulness &#x02013; in contrast to the sleep disturbance observed in <related-object link-type="booklink" source-id="gene" document-id="sms" document-type="chapter">Smith Magenis syndrome</related-object>.</p>
          <p>Longitudinal data are insufficient to determine life expectancy; however, it should be noted that death in infancy or childhood can occur from complications such as heart defects and recurrent aspiration and pulmonary infections [<xref ref-type="bibr" rid="kleefstra.REF.stewart.2007.383">Stewart &#x00026; Kleefstra 2007</xref>].</p>
        </sec>
        <sec id="kleefstra.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Current data indicate that individuals with an intragenic <italic toggle="yes">EHMT1</italic> pathogenic variant (e.g., a missense or nonsense variant) and those with a small (&#x0003c;1 Mb) 9q34.3 microdeletion have similar clinical findings. Individuals with larger deletions (&#x02265;1 Mb), however, have more somatic problems. Pulmonary infections and aspiration difficulties in particular appear to be more severe in individuals with larger 9q34 deletions than in those with smaller deletions or <italic toggle="yes">EHMT1</italic> pathogenic variants only.</p>
        </sec>
        <sec id="kleefstra.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is likely to be 100%: clinical features of Kleefstra syndrome are apparent in all individuals with inactivation of one <italic toggle="yes">EHMT1</italic> allele, although the extent and severity of clinical findings vary among individuals.</p>
        </sec>
        <sec id="kleefstra.Nomenclature">
          <title>Nomenclature</title>
          <p>The disorder was first recognized following widespread subtelomeric FISH studies [<xref ref-type="bibr" rid="kleefstra.REF.knight.1999.1676">Knight et al 1999</xref>, <xref ref-type="bibr" rid="kleefstra.REF.dawson.2002.488">Dawson et al 2002</xref>]. After the identification of an individual with a similar phenotype and a <italic toggle="yes">de novo</italic> balanced translocation disrupting <italic toggle="yes">EHMT1</italic>, it was hypothesized that haploinsufficiency of this gene caused the phenotype present in individuals with a 9q34 deletion [<xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2005.299">Kleefstra et al 2005</xref>]. Subsequent identification of additional individuals with intragenic <italic toggle="yes">EHMT1</italic> defects led OMIM to assign the name Kleefstra to the syndrome.</p>
        </sec>
        <sec id="kleefstra.Prevalence">
          <title>Prevalence</title>
          <p>Reliable figures on penetrance are not yet available. Based on data from other rare disorders involving intellectual disability, Kleefstra syndrome is estimated to affect at least 1:200,000 individuals; as many individuals with this condition are not diagnosed, the true prevalence may be much higher.</p>
          <p>The syndrome has been identified worldwide and in all ethnic groups.</p>
        </sec>
      </sec>
      <sec id="kleefstra.Genetically_Related_Allelic_Di">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with deletion in the genes located within the 9q34.3 critical region or with pathogenic variants in <italic toggle="yes">EHMT1</italic>.</p>
      </sec>
      <sec id="kleefstra.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Disorders in the differential diagnosis of Kleefstra syndrome:</p>
        <list list-type="bullet">
          <list-item>
            <p>Down syndrome</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="sms" document-type="chapter">Smith-Magenis syndrome</related-object> (SMS)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="pitt-hopkins" document-type="chapter">Pitt-Hopkins syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Rett syndrome (see <related-object link-type="booklink" source-id="gene" document-id="rett" document-type="chapter"><italic toggle="yes">MECP2</italic>-Related Disorders</related-object>)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="del2q37_2" document-type="chapter">2q37 deletion syndrome</related-object>
            </p>
          </list-item>
        </list>
      </sec>
      <sec id="kleefstra.Management">
        <title>Management</title>
        <sec id="kleefstra.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with the Kleefstra syndrome, the following evaluations are recommended following the initial diagnosis:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete review of systems</p>
            </list-item>
            <list-item>
              <p>Physical and neurologic examination</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound examination to evaluate for possible renal/urologic anomalies</p>
            </list-item>
            <list-item>
              <p>Echocardiogram and ECG to evaluate for possible structural cardiac anomalies and atrial rhythm defects; follow-up depending on the severity of any cardiac anomaly identified</p>
            </list-item>
            <list-item>
              <p>Speech/language evaluation including audiologic examination</p>
            </list-item>
            <list-item>
              <p>Assessment for signs and symptoms of gastroesophageal reflux (GER)</p>
            </list-item>
            <list-item>
              <p>Physical and/or occupational therapy assessment</p>
            </list-item>
            <list-item>
              <p>Sleep history</p>
            </list-item>
            <list-item>
              <p>EEG if seizures are suspected</p>
            </list-item>
            <list-item>
              <p>Neuroimaging (MRI) especially in the presence of findings such as seizures and/or movement disorder, extreme apathy/catatonia, and/or regression in psychomotor development</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="kleefstra.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The following are indicated:</p>
          <list list-type="bullet">
            <list-item>
              <p>Ongoing routine pediatric care by a pediatrician or neurologist, psychiatrist, and/or (for adults) specialist in the care of adults with intellectual disability</p>
            </list-item>
            <list-item>
              <p>Depending on the age of the affected individual, referral to an early childhood intervention program, ongoing special education programs, and/or vocational training</p>
            </list-item>
            <list-item>
              <p>Speech/language therapy, physical and occupational therapy, and sensory integration therapy</p>
            </list-item>
            <list-item>
              <p>Specialized neurologic and psychiatric care for individuals with extreme behavior problems and/or movement disorder. Behavioral therapies include special education techniques that may help minimize behavioral outbursts in the school setting by emphasizing individualized instruction, structure, and a set daily routine.</p>
            </list-item>
            <list-item>
              <p>Therapeutic management of the sleep disorder. No well-controlled treatment trials have been reported</p>
            </list-item>
            <list-item>
              <p>Specialized neurologic care for individuals with epilepsy; management of seizures in accordance with standard practice</p>
            </list-item>
            <list-item>
              <p>Standard treatment for cardiac, renal, urologic, and other medical issues</p>
            </list-item>
            <list-item>
              <p>Auditory amplification if hearing loss is identified</p>
            </list-item>
          </list>
        </sec>
        <sec id="kleefstra.Surveillance">
          <title>Surveillance</title>
          <p>Cardiac and renal/urologic abnormalities should be monitored as needed.</p>
        </sec>
        <sec id="kleefstra.Evaluation_of_Relatives_at_Ris">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="kleefstra.Related_Genetic_Counseling_Iss">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="kleefstra.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="kleefstra.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="kleefstra.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Kleefstra syndrome, caused by a microdeletion at 9q34.3 or an intragenic <italic toggle="yes">EHMT1</italic> pathogenic variant<italic toggle="yes">,</italic> is inherited in an autosomal dominant manner; almost all cases reported to date have been <italic toggle="yes">de novo</italic>.</p>
        </sec>
        <sec id="kleefstra.Risk_to_Family_Members__9q34_3">
          <title>Risk to Family Members &#x02014; 9q34.3 Microdeletion</title>
          <p><bold>9q34.3 microdeletion</bold> is usually <italic toggle="yes">de novo</italic> but may be inherited as the result of a complex chromosomal rearrangement or mosaicism in a parent.</p>
        </sec>
        <sec id="kleefstra.Parents_of_a_proband">
          <title>Parents of a proband</title>
          <list list-type="bullet">
            <list-item>
              <p>To date, no parent-to-child transmission of an unbalanced derivative chromosome involving the 9q34.3 region has been observed.</p>
            </list-item>
            <list-item>
              <p>Recurrence in families with a parent having a balanced translocation involving the 9q34.3 region has been described [<xref ref-type="bibr" rid="kleefstra.REF.knight.1999.1676">Knight et al 1999</xref>, <xref ref-type="bibr" rid="kleefstra.REF.dawson.2002.488">Dawson et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>To date, all interstitial 9q34.3 microdeletions detected are <italic toggle="yes">de novo</italic>, except for three families in which one of the parents was shown to have a somatic mosaic deletion. In one family, a parent with learning difficulties had two severely affected children; in another family, a parent with learning difficulties had one affected child [Author, personal observation].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of asymptomatic parents of a proband with a 9q34.3 microdeletion include routine karyotyping with additional FISH analysis to determine if a balanced chromosomal rearrangement involving the 9q34.3 region is present.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the parents.</p>
            </list-item>
            <list-item>
              <p>In the (unlikely) event that a parent has either germline mosaicism for a 9q34.3 microdeletion, low-level somatic mosaicism that includes the germline, or a balanced structural chromosome rearrangement involving the 9q34.3 region, the risk to sibs is increased. The estimated risk depends on the specific chromosome rearrangement.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>To date, five individuals diagnosed with a mosaic 9q34.3 microdeletion have been known to reproduce [<xref ref-type="bibr" rid="kleefstra.REF.willemsen.2011.31">Willemsen et al 2011</xref>; T Kleefstra, personal communication].</p>
            </list-item>
            <list-item>
              <p>Individuals who have the 9q34.3 microdeletion would be expected to have a 50% chance of transmitting the deletion to each child.</p>
            </list-item>
          </list>
        </sec>
        <sec id="kleefstra.Risk_to_Family_Members__EHMT1">
          <title>Risk to Family Members &#x02014; <italic toggle="yes">EHMT1</italic> Pathogenic Variant</title>
          <p><bold>Mutation of <italic toggle="yes">EHMT1</italic></bold> in almost all cases to date has occurred <italic toggle="yes">de novo</italic>.</p>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>To date, only one parent of an individual with an <italic toggle="yes">EHMT1</italic> pathogenic variant has also had the pathogenic variant, although it was a mosaic pathogenic variant in an unaffected parent [<xref ref-type="bibr" rid="kleefstra.REF.rump.2013.887">Rump et al 2013</xref>]; therefore, in the vast majority of cases <italic toggle="yes">EHMT1</italic> mutation has occurred <italic toggle="yes">de novo</italic>. All individuals are simplex cases (i.e., a single occurrence in the family).</p>
            </list-item>
            <list-item>
              <p>When the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, germline mosaicism in a parent is also a possibility [<xref ref-type="bibr" rid="kleefstra.REF.rump.2013.887">Rump et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing for the specific <italic toggle="yes">EHMT1</italic> pathogenic variant identified in the proband<italic toggle="yes">.</italic></p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the parents.</p>
            </list-item>
            <list-item>
              <p>In the (unlikely) event that a parent has germline mosaicism or low-level somatic mosaicism for an <italic toggle="yes">EHMT1</italic> pathogenic variant that also includes the germline, the risk to sibs is increased.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>No individual with a non-mosaic <italic toggle="yes">EHMT1</italic> pathogenic variant has been known to reproduce.</p>
            </list-item>
            <list-item>
              <p>Individuals who have a non-mosaic <italic toggle="yes">EHMT1</italic> pathogenic variant would be expected to have a 50% chance of transmitting the pathogenic variant to each child.</p>
            </list-item>
          </list>
        </sec>
        <sec id="kleefstra.Related_Genetic_Counseling_Iss">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who may be at risk of having a child with Kleefstra syndrome.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="kleefstra.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Prenatal testing for at-risk pregnancies requires prior identification of the 9q34.3 microdeletion or an <italic toggle="yes">EHMT1</italic> pathogenic variant in the proband and/or of balanced carrier status in a parent. Prenatal testing may be offered to unaffected parents who have had a child with a 9q34.3 microdeletion or an <italic toggle="yes">EHMT1</italic> pathogenic variant because of the recurrence risk associated with the possibility of germline mosaicism, somatic mosaicism including the germline, or a balanced chromosome translocation.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>9q34.3 microdeletion.</bold> Chromosome preparations from fetal cells obtained by amniocentesis usually performed at approximately 15 to 18 weeks' gestation or CVS at approximately ten to 12 weeks' gestation can be analyzed using FISH or MLPA in the manner described in Diagnosis, <xref ref-type="sec" rid="kleefstra.Establishing_the_Diagnosis">Establishing the Diagnosis</xref>.</p>
            </list-item>
            <list-item>
              <p><bold>Intragenic <italic toggle="yes">EHMT1</italic> pathogenic variant.</bold> DNA preparations from fetal cells obtained by CVS at approximately ten to 12 weeks' gestation (or amniocentesis usually performed at approximately 15 to 18 weeks' gestation) can be tested for the <italic toggle="yes">EHMT1</italic> pathogenic variant identified in the proband.</p>
            </list-item>
          </list>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for families at increased risk for a pregnancy with the 9q34.3 microdeletion or an <italic toggle="yes">EHMT1</italic> pathogenic variant.</p>
        </sec>
      </sec>
      <sec id="kleefstra.Resources">
        <title>Resources</title>
      </sec>
      <sec id="kleefstra.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> The previously defined <italic toggle="yes">EHMT1</italic> transcript (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/40217807">NM_024757.3</ext-link>) contained 26 exons, the translation start site being located in exon 2. The 'updated' <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_024757.4">NM_024757.4</ext-link> version varies significantly, and contains an extra 5' exon. The novel open reading frame comprises 27 coding exons. The translation start site is located in the "novel" exon 1, 97.6 kb proximal to the &#x02018;old&#x02019; ATG start codon. Diagnostic testing so far has been directed towards the 25 coding exons of the <italic toggle="yes">EHMT1</italic> NM_024757.3 sequence. Since three individuals with Kleefstra syndrome harbor interstitial 9q microdeletions encompassing only this novel <italic toggle="yes">EHMT1</italic> sequence in addition to several proximally located genes [Author, personal observation], routine diagnostic testing should be adjusted to the novel transcript. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="kleefstra" object-id="kleefstra.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants</bold>. <italic toggle="yes">EHMT1</italic> sequence variants include nonsense, splice site, and missense variants and small deletions and duplications (<xref ref-type="table" rid="kleefstra.T.selected_pathogenic_ehmt1_al">Table 2</xref>) [<xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2006a.370">Kleefstra et al 2006a</xref>, <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</xref>, <xref ref-type="bibr" rid="kleefstra.REF.willemsen.2012.202">Willemsen et al 2012</xref>]. Note: The nomenclature has been adjusted for the &#x02018;updated&#x02019; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_024757.4">NM_024757.4</ext-link> sequence.</p>
        <table-wrap id="kleefstra.T.selected_pathogenic_ehmt1_al" position="anchor" orientation="portrait">
          <label>Table 2. </label>
          <caption>
            <p>Selected Pathogenic <italic toggle="yes">EHMT1</italic> Allelic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias)&#x000a0;<sup>1</sup></th>
                <th id="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.871C&#x0003e;T</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg291Ter</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_3" rowspan="16" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_024757.4">NM_024757.4</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_079033.4">NP_079033.4</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1413_1425del</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro473GlnfsTer86</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1533_1536del</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp512AlafsTer50</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1810C&#x0003e;T</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln604Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1858C&#x0003e;T</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg620Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2028dup</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro677AlafsTer21</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2193-1G&#x0003e;C</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.?</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2863_2864delGT</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val955ArgfsTer221</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2868-1G&#x0003e;A</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">r.spl?</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2877_2880delTTCT (2878_2881del)</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser960GlyfsTer7</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3181-80_3233del</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">r.spl?&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3180+1G&#x0003e;T</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">r.spl?</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3218G&#x0003e;A</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys1073Tyr</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3229C&#x0003e;T</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln1077Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3502C&#x0003e;T</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1168Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3589C&#x0003e;T</td>
                <td headers="hd_h_kleefstra.T.selected_pathogenic_ehmt1_al_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1197Trp</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn>
              <p>p.? indicates that a protein has not been analyzed; an effect is expected but difficult to predict.</p>
            </fn>
            <fn>
              <p>r.spl? designates a change expected to affect splicing.</p>
            </fn>
            <fn id="kleefstra.TF.2.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
            <fn id="kleefstra.TF.2.2">
              <label>2. </label>
              <p>Donor splice site</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_024757.4">NM_024757.4</ext-link> transcript encodes a protein of 1298 amino acid residues. <italic toggle="yes">EHMT1</italic> encodes euchromatin histone-lysine N-methyl transferase 1, a protein involved in histone methylation. DNA is wrapped around histones, and histone tails have an important role in folding of chromatin fibers. Methylation of these histone tails is thought to regulate this folding process, hereby altering the accessibility of DNA to proteins mediating transcription [<xref ref-type="bibr" rid="kleefstra.REF.martin.2005.838">Martin &#x00026; Zhang 2005</xref>]. The restricted expression of <italic toggle="yes">EHMT1</italic> in the mouse brain (olfactory bulb, the anterior/ventral ventricular wall, hippocampus, and piriform cortex) supports a role of epigenetic histone modification in normal brain development [<xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2005.299">Kleefstra et al 2005</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Haploinsufficiency resulting from deletion or inactivation of one <italic toggle="yes">EHMT1</italic> allele is the cause of Kleefstra syndrome. The majority of pathogenic variants disrupt the open reading frame of <italic toggle="yes">EHMT1</italic> and are predicted to lead to nonsense-mediated decay. The one pathogenic missense variant described to date is predicted to have an influence on the local conformation of the pre-SET domain of the EHMT1 protein, thereby reflecting a null allele [<xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2009.598">Kleefstra et al 2009</xref>]. Besides <italic toggle="yes">EHMT1</italic>, other genes associated with intellectual disability (e.g., <italic toggle="yes">MECP2</italic>, <italic toggle="yes">RSK2</italic>, and <italic toggle="yes">XNP</italic>) appear to play a role in chromatin remodeling [<xref ref-type="bibr" rid="kleefstra.REF.ausi_.2003.83">Ausi&#x000f3; et al 2003</xref>]. Loss of proper regulation of chromatin structure can result in deregulation of gene transcription and inappropriate protein expression. This can in turn contribute to complex genetic disorders including intellectual disability.</p>
      </sec>
      <sec id="kleefstra.References">
        <title>References</title>
        <sec id="kleefstra.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="kleefstra.Literature_Cited.reflist0">
            <ref id="kleefstra.REF.ausi_.2003.83">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ausi&#x000f3;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Amorim</surname>
                    <given-names>GV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacLeod</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Syndromes of disordered chromatin remodeling.</article-title>
                <source>Clin Genet</source>
                <volume>64</volume>
                <fpage>83</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">12859401</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.cormierdaire.2003.300">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molinari</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raoul</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Blois</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romana</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colleaux</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Cryptic terminal deletion of chromosome 9q34: a novel cause of syndromic obesity in childhood?</article-title>
                <source>J Med Genet.</source>
                <volume>40</volume>
                <fpage>300</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">12676904</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.dawson.2002.488">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dawson</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Putnam</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riordan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prasad</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chodirker</surname>
                    <given-names>BN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mhanni</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chudley</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cryptic chromosome rearrangements detected by subtelomere assay in patients with mental retardation and dysmorphic features.</article-title>
                <source>Clin Genet</source>
                <volume>62</volume>
                <fpage>488</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">12515261</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.kleefstra.2006a.370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kleefstra</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oudakker</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nillesen</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magee</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genevi&#x000e8;ve</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Esch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>BB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2006a</year>
                <volume>79</volume>
                <fpage>370</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16826528</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.kleefstra.2006b.618">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kleefstra</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koolen</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nillesen</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Leeuw</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veltman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ravenswaay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>BB</given-names>
                  </name>
                </person-group>
                <article-title>Interstitial 2.2 Mb deletion at 9q34 in a patient with mental retardation but without classical features of the 9q subtelomeric deletion syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2006b</year>
                <volume>140</volume>
                <fpage>618</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">16470689</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.kleefstra.2005.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kleefstra</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smidt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banning</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oudakker</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Esch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Brouwer</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nillesen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bruijn</surname>
                    <given-names>D</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2005</year>
                <article-title>Disruption of the gene euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome.</article-title>
                <source>J Med Genet</source>
                <volume>42</volume>
                <fpage>299</fpage>
                <lpage>306</lpage>
                <pub-id pub-id-type="pmid">15805155</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.kleefstra.2009.598">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kleefstra</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Zelst-Stams</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nillesen</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houge</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulds</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dooren</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfundt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGaughran</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zenker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adam</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Innes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casalone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brueton</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarro</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bralo</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venselaar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stegmann</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yntema</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.</article-title>
                <source>J Med Genet.</source>
                <volume>46</volume>
                <fpage>598</fpage>
                <lpage>606</lpage>
                <pub-id pub-id-type="pmid">19264732</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.knight.1999.1676">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Knight</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicod</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horsley</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kearney</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Homfray</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flint</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Subtle chromosomal rearrangements in children with unexplained mental retardation.</article-title>
                <source>Lancet</source>
                <volume>354</volume>
                <fpage>1676</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">10568569</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.martin.2005.838">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>The diverse functions of histone lysine methylation.</article-title>
                <source>Nat Rev Mol Cell Biol.</source>
                <year>2005</year>
                <volume>6</volume>
                <fpage>838</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">16261189</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.rump.2013.887">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rump</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrand</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tzschach</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ullmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schrock</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitter</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>A mosaic maternal splice donor mutation in the EHMT1 gene leads to aberrant transcripts and to Kleefstra syndrome in the offspring.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2013</year>
                <volume>21</volume>
                <fpage>887</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">23232695</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.stewart.2004.340">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faravelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderlid</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medne</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciprero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaur</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordenskj&#x000f6;ld</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gripp</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meschino</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capua</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quarrell</surname>
                    <given-names>OW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flint</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irons</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giampietro</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schowalter</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaleski</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malacarne</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krantz</surname>
                    <given-names>ID</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Subtelomeric deletions of chromosome 9q: a novel microdeletion syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>128A</volume>
                <fpage>340</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15264279</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.stewart.2007.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleefstra</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The chromosome 9q subtelomere deletion syndrome.</article-title>
                <source>Am J Med Genet C Semin Med Genet.</source>
                <volume>145C</volume>
                <fpage>383</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17910072</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.verhoeven.2010.536">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verhoeven</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleefstra</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egger</surname>
                    <given-names>JI</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Behavioral phenotype in the 9q subtelomeric deletion syndrome: a report about two adult patients.</article-title>
                <source>Am J Med Genet B Neuropsychiatr Genet</source>
                <volume>153B</volume>
                <fpage>536</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">19642112</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.willemsen.2011.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beunders</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callaghan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Leeuw</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nillesen</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yntema</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Hagen</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nieuwint</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keijzers-Vloet</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoischen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolmie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleefstra</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Familial Kleefstra syndrome due to maternal somatic mosaicism for interstitial 9q34.3 microdeletions.</article-title>
                <source>Clin Genet.</source>
                <year>2011</year>
                <volume>80</volume>
                <fpage>31</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21204793</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.willemsen.2012.202">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vulto-van Silfhout</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nillesen</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wissink-Lindhout</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philip</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry-Kravis</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kini</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ravenswaaij-Arts</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delle Chiaie</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Innes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houge</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosonen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fannemel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stray-Pedersen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ignatius</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachlan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mircher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helderman van den Enden</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mastebroek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn-Hokke</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yntema</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drunat</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Kleefstra: Update on Kleefstra Syndrome</article-title>
                <source>Mol Syndromol.</source>
                <year>2012</year>
                <volume>2</volume>
                <fpage>202</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">22670141</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.yatsenko.2009.1924">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yatsenko</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brundage</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roney</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinault</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>18</volume>
                <fpage>1924</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">19293338</pub-id>
              </element-citation>
            </ref>
            <ref id="kleefstra.REF.yatsenko.2005.328">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yatsenko</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowaczyk</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarnopolsky</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bibat</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaglia</surname>
                    <given-names>F</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2005</year>
                <article-title>Deletion 9q34.3 syndrome: genotype-phenotype correlations and an extended deletion in a patient with features of Opitz C trigonocephaly.</article-title>
                <source>J Med Genet</source>
                <volume>42</volume>
                <fpage>328</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">15805160</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="kleefstra.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="kleefstra.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>7 May 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>5 October 2010 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>28 May 2010 (tk) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="kleefstra.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Photographs of affected individuals showing the characteristic facial profile comprising brachycephaly, widely spaced eyes, synophrys/arched eyebrows, midfaceretrusion, protruding tongue, eversion of the vermilion of the lower lip, and prognathism of chin. Five people(AB), (CD), (EF), (GH) and (IJ) with <italic toggle="yes">EHMT1</italic> pathogenic variants are shown.Reproduced from <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2009.598">Kleefstra et al [2009]</xref> with permission from BMJ Publishing Group Ltd.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="kleefstra-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="kleefstra.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Photographs of affected individuals showing the characteristic facial profile comprising brachycephaly, widely spaced eyes, synophrys/arched eyebrows, midface retrusion, protruding tongue, eversion of the vermilion of the lower lip, and prognathism of the chin. Three different people (rows A, B, and C) with interstitial 9q34.3 microdeletions at different ages show evolution with age.Reproduced from <xref ref-type="bibr" rid="kleefstra.REF.kleefstra.2009.598">Kleefstra et al [2009]</xref> with permission from BMJ Publishing Group Ltd.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="kleefstra-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
